| Year |
Citation |
Score |
| 2020 |
Benson CA, Powell HR, Liput M, Dinham S, Freedman DA, Ignatowski TA, Stachowiak EK, Stachowiak MK. Immune Factor, TNFα, Disrupts Human Brain Organoid Development Similar to Schizophrenia-Schizophrenia Increases Developmental Vulnerability to TNFα. Frontiers in Cellular Neuroscience. 14: 233. PMID 33005129 DOI: 10.3389/Fncel.2020.00233 |
0.343 |
|
| 2018 |
Narla ST, Decker B, Sarder P, Stachowiak EK, Stachowiak MK. Induced Pluripotent Stem Cells Reveal Common Neurodevelopmental Genome Deprograming in Schizophrenia. Results and Problems in Cell Differentiation. 66: 137-162. PMID 30209658 DOI: 10.1007/978-3-319-93485-3_6 |
0.355 |
|
| 2015 |
Förthmann B, Aletta JM, Lee YW, Terranova C, Birkaya B, Stachowiak EK, Stachowiak MK, Claus P. Coalition of Nuclear Receptors in the Nervous System. Journal of Cellular Physiology. PMID 25966815 DOI: 10.1002/Jcp.25036 |
0.621 |
|
| 2015 |
Terranova C, Narla ST, Lee YW, Bard J, Parikh A, Stachowiak EK, Tzanakakis ES, Buck MJ, Birkaya B, Stachowiak MK. Global Developmental Gene Programing Involves a Nuclear Form of Fibroblast Growth Factor Receptor-1 (FGFR1). Plos One. 10: e0123380. PMID 25923916 DOI: 10.1371/Journal.Pone.0123380 |
0.593 |
|
| 2015 |
Stachowiak MK, Birkaya B, Aletta JM, Narla ST, Benson CA, Decker B, Stachowiak EK. "Nuclear FGF receptor-1 and CREB binding protein: an integrative signaling module". Journal of Cellular Physiology. 230: 989-1002. PMID 25503065 DOI: 10.1002/Jcp.24879 |
0.333 |
|
| 2015 |
Kucinski A, Wersinger S, Stachowiak EK, Becker C, Lippiello P, Bencherif M, Stachowiak MK. The effects of varenicline on sensory gating and exploratory behavior with pretreatment with nicotinic or 5-HT3A receptor antagonists. Behavioural Pharmacology. 26: 217-26. PMID 25485645 DOI: 10.1097/Fbp.0000000000000122 |
0.719 |
|
| 2014 |
Miletich RS, Kucinski A, Narla S, Benson C, Wersinger S, Corso TD, Bencherif M, Stachowiak EK, Stachowiak MK. Schizophrenia and the dopaminergic system The Central Catecholaminergic System: Anatomy, Functions and Disorders. 157-177. |
0.705 |
|
| 2014 |
Kucinski A, Curl R, Miletich RS, Corso TD, Stachowiak EK, Stachowiak MK. The role of fibroblast growth factor (FGF) signaling on dopaminergic function in Parkinson's disease The Central Catecholaminergic System: Anatomy, Functions and Disorders. 143-156. |
0.681 |
|
| 2013 |
Förthmann B, van Bergeijk J, Lee YW, Lübben V, Schill Y, Brinkmann H, Ratzka A, Stachowiak MK, Hebert M, Grothe C, Claus P. Regulation of neuronal differentiation by proteins associated with nuclear bodies. Plos One. 8: e82871. PMID 24358231 DOI: 10.1371/Journal.Pone.0082871 |
0.579 |
|
| 2013 |
Narla ST, Klejbor I, Birkaya B, Lee YW, Morys J, Stachowiak EK, Prokop D, Bencherif M, Stachowiak MK. Activation of developmental nuclear fibroblast growth factor receptor 1 signaling and neurogenesis in adult brain by α7 nicotinic receptor agonist. Stem Cells Translational Medicine. 2: 776-88. PMID 24014683 DOI: 10.5966/sctm.2012-0103 |
0.626 |
|
| 2013 |
Narla S, Klejbor I, Birkaya B, Lee YW, Morys J, Stachowiak EK, Terranova C, Bencherif M, Stachowiak MK. α7 nicotinic receptor agonist reactivates neurogenesis in adult brain. Biochemical Pharmacology. 86: 1099-104. PMID 23933384 DOI: 10.1016/j.bcp.2013.07.028 |
0.603 |
|
| 2013 |
Lee YW, Stachowiak EK, Birkaya B, Terranova C, Capacchietti M, Claus P, Aletta JM, Stachowiak MK. NGF-induced cell differentiation and gene activation is mediated by integrative nuclear FGFR1 signaling (INFS). Plos One. 8: e68931. PMID 23874817 DOI: 10.1371/Journal.Pone.0068931 |
0.591 |
|
| 2013 |
Kucinski A, Wersinger S, Stachowiak EK, Corso TD, Parry MJ, Zhang J, Jordan K, Letchworth S, Bencherif M, Stachowiak MK. Neuronal nicotinic receptor agonists ameliorate spontaneous motor asymmetries and motor discoordination in a unilateral mouse model of Parkinson's disease. Pharmacology, Biochemistry, and Behavior. 111: 1-10. PMID 23872135 DOI: 10.1016/j.pbb.2013.07.005 |
0.716 |
|
| 2013 |
Stachowiak MK, Kucinski A, Curl R, Syposs C, Yang Y, Narla S, Terranova C, Prokop D, Klejbor I, Bencherif M, Birkaya B, Corso T, Parikh A, Tzanakakis ES, Wersinger S, et al. Schizophrenia: a neurodevelopmental disorder--integrative genomic hypothesis and therapeutic implications from a transgenic mouse model. Schizophrenia Research. 143: 367-76. PMID 23231877 DOI: 10.1016/J.Schres.2012.11.004 |
0.756 |
|
| 2012 |
Lee YW, Terranova C, Birkaya B, Narla S, Kehoe D, Parikh A, Dong S, Ratzka A, Brinkmann H, Aletta JM, Tzanakakis ES, Stachowiak EK, Claus P, Stachowiak MK. A novel nuclear FGF Receptor-1 partnership with retinoid and Nur receptors during developmental gene programming of embryonic stem cells. Journal of Cellular Biochemistry. 113: 2920-36. PMID 22539306 DOI: 10.1002/Jcb.24170 |
0.579 |
|
| 2012 |
Ratzka A, Baron O, Stachowiak MK, Grothe C. Fibroblast growth factor 2 regulates dopaminergic neuron development in vivo. Journal of Neurochemistry. 122: 94-105. PMID 22537018 DOI: 10.1111/j.1471-4159.2012.07768.x |
0.338 |
|
| 2012 |
Baron O, Förthmann B, Lee YW, Terranova C, Ratzka A, Stachowiak EK, Grothe C, Claus P, Stachowiak MK. Cooperation of nuclear fibroblast growth factor receptor 1 and Nurr1 offers new interactive mechanism in postmitotic development of mesencephalic dopaminergic neurons. The Journal of Biological Chemistry. 287: 19827-40. PMID 22514272 DOI: 10.1074/jbc.M112.347831 |
0.647 |
|
| 2012 |
Bencherif M, Stachowiak MK, Kucinski AJ, Lippiello PM. Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia. Medical Hypotheses. 78: 594-600. PMID 22336089 DOI: 10.1016/j.mehy.2012.01.035 |
0.74 |
|
| 2012 |
Kucinski A, Syposs C, Wersinger S, Bencherif M, Stachowiak MK, Stachowiak EK. α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia. Schizophrenia Research. 136: 82-7. PMID 22285656 DOI: 10.1016/J.Schres.2012.01.005 |
0.754 |
|
| 2012 |
Kucinski A, Wersinger S, Stachowiak EK, Radell M, Hesse R, Corso T, Parry M, Bencherif M, Jordan K, Letchworth S, Stachowiak MK. Unilateral 6-OHDA <i>th-fgfr1</i>(<i>tk-</i>) mouse model supports the role of FGFs in Parkinson’s disease and the effects of nicotine and L-DOPA on spontaneous motor impairments Health. 4: 1178-1190. DOI: 10.4236/Health.2012.431176 |
0.721 |
|
| 2011 |
Kucinski AJ, Stachowiak MK, Wersinger SR, Lippiello PM, Bencherif M. Alpha7 neuronal nicotinic receptors as targets for novel therapies to treat multiple domains of schizophrenia. Current Pharmaceutical Biotechnology. 12: 437-48. PMID 21133847 DOI: 10.2174/138920111794480589 |
0.744 |
|
| 2009 |
Stachowiak EK, Roy I, Lee YW, Capacchietti M, Aletta JM, Prasad PN, Stachowiak MK. Targeting novel integrative nuclear FGFR1 signaling by nanoparticle-mediated gene transfer stimulates neurogenesis in the adult brain. Integrative Biology : Quantitative Biosciences From Nano to Macro. 1: 394-403. PMID 20023746 DOI: 10.1039/B902617G |
0.589 |
|
| 2009 |
Klejbor I, Kucinski A, Wersinger SR, Corso T, Spodnik JH, Dziewiatkowski J, MoryÅ› J, Hesse RA, Rice KC, Miletich R, Stachowiak EK, Stachowiak MK. Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis. Schizophrenia Research. 113: 308-21. PMID 19570652 DOI: 10.1016/J.Schres.2009.06.006 |
0.746 |
|
| 2009 |
Hauser TA, Kucinski A, Jordan KG, Gatto GJ, Wersinger SR, Hesse RA, Stachowiak EK, Stachowiak MK, Papke RL, Lippiello PM, Bencherif M. TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia. Biochemical Pharmacology. 78: 803-12. PMID 19482012 DOI: 10.1016/J.Bcp.2009.05.030 |
0.732 |
|
| 2009 |
Dunham-Ems SM, Lee YW, Stachowiak EK, Pudavar H, Claus P, Prasad PN, Stachowiak MK. Fibroblast growth factor receptor-1 (FGFR1) nuclear dynamics reveal a novel mechanism in transcription control. Molecular Biology of the Cell. 20: 2401-12. PMID 19261810 DOI: 10.1091/Mbc.E08-06-0600 |
0.543 |
|
| 2008 |
Kucinski A, Klejbor I, Wersinger S, Hesse R, Stachowiak E, Stachowiak M. [P1.68]: Disruption in the integrative FGF receptor signaling may serve as a common pathological mechanism for the diverse genetic defects linked to schizophrenia International Journal of Developmental Neuroscience. 26: 864-864. DOI: 10.1016/J.Ijdevneu.2008.09.118 |
0.713 |
|
| 2006 |
Klejbor I, Myers JM, Hausknecht K, Corso TD, Gambino AS, Morys J, Maher PA, Hard R, Richards J, Stachowiak EK, Stachowiak MK. Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - Inhibition results in a schizophrenia-like syndrome in transgenic mice Journal of Neurochemistry. 97: 1243-1258. PMID 16524369 DOI: 10.1111/j.1471-4159.2006.03754.x |
0.398 |
|
| 2005 |
Corso TD, Torres G, Goulah C, Roy I, Gambino AS, Nayda J, Buckley T, Stachowiak EK, Bergey EJ, Pudavar H, Dutta P, Bloom DC, Bowers WJ, Stachowiak MK. Transfection of tyrosine kinase deleted FGF receptor-1 into rat brain substantia nigra reduces the number of tyrosine hydroxylase expressing neurons and decreases concentration levels of striatal dopamine. Brain Research. Molecular Brain Research. 139: 361-6. PMID 16039006 DOI: 10.1016/J.Molbrainres.2005.05.032 |
0.375 |
|
| 2005 |
Fang X, Stachowiak EK, Dunham-Ems SM, Klejbor I, Stachowiak MK. Control of CREB-binding protein signaling by nuclear fibroblast growth factor receptor-1: a novel mechanism of gene regulation. The Journal of Biological Chemistry. 280: 28451-62. PMID 15929978 DOI: 10.1074/Jbc.M504400200 |
0.511 |
|
| 2004 |
Hu Y, Fang X, Dunham SM, Prada C, Stachowiak EK, Stachowiak MK. 90-kDa ribosomal S6 kinase is a direct target for the nuclear fibroblast growth factor receptor 1 (FGFR1): role in FGFR1 signaling. The Journal of Biological Chemistry. 279: 29325-35. PMID 15117958 DOI: 10.1074/Jbc.M311144200 |
0.489 |
|
| 2003 |
Stachowiak MK, Fang X, Myers JM, Dunham SM, Berezney R, Maher PA, Stachowiak EK. Integrative nuclear FGFR1 signaling (INFS) as a part of a universal "feed-forward-and-gate" signaling module that controls cell growth and differentiation. Journal of Cellular Biochemistry. 90: 662-91. PMID 14587025 DOI: 10.1002/Jcb.10606 |
0.504 |
|
| 2003 |
Stachowiak EK, Fang X, Myers J, Dunham S, Stachowiak MK. cAMP-induced differentiation of human neuronal progenitor cells is mediated by nuclear fibroblast growth factor receptor-1 (FGFR1). Journal of Neurochemistry. 84: 1296-312. PMID 12614330 DOI: 10.1046/J.1471-4159.2003.01624.X |
0.549 |
|
| 2003 |
Bużańska L, Stachowiak E, Stachowiak M, Domańska-Janik K. Neural stem cell line derived from human umbilical cord blood – morphological and functional properties Journal of Neurochemistry. 85: 33-33. DOI: 10.1046/J.1471-4159.85.S2.21_2.X |
0.371 |
|
| 2002 |
Peng H, Myers J, Fang X, Stachowiak EK, Maher PA, Martins GG, Popescu G, Berezney R, Stachowiak MK. Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C Journal of Neurochemistry. 81: 506-524. PMID 12065659 DOI: 10.1046/J.1471-4159.2002.00833.X |
0.528 |
|
| 2002 |
Horbinski C, Stachowiak EK, Chandrasekaran V, Miuzukoshi E, Higgins D, Stachowiak MK. Bone morphogenetic protein-7 stimulates initial dendritic growth in sympathetic neurons through an intracellular fibroblast growth factor signaling pathway. Journal of Neurochemistry. 80: 54-63. PMID 11796743 DOI: 10.1046/J.0022-3042.2001.00657.X |
0.324 |
|
| 2001 |
Peng H, Moffett J, Myers J, Fang X, Stachowiak EK, Maher P, Kratz E, Hines J, Fluharty SJ, Mizukoshi E, Bloom DC, Stachowiak MK. Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors. Molecular Biology of the Cell. 12: 449-62. PMID 11179427 DOI: 10.1091/Mbc.12.2.449 |
0.511 |
|
| 1988 |
Stachowiak M, Stricker EM, Zigmond MJ, Kaplan BB. A cholinergic antagonist blocks cold stress-induced alterations in rat adrenal tyrosine hydroxylase mRNA. Brain Research. 427: 193-5. PMID 2898270 DOI: 10.1016/0169-328X(88)90066-6 |
0.325 |
|
| 1987 |
Stachowiak MK, Keller RW, Stricker EM, Zigmond MJ. Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 7: 1648-54. PMID 3110381 DOI: 10.1523/Jneurosci.07-06-01648.1987 |
0.324 |
|
| Show low-probability matches. |